Subdermal Contraceptive Implants Market size is poised to cross USD 3 Billion by the end of 2036, growing at a CAGR of 9% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of subdermal contraceptive implants was USD 1.05 Billion. The reason behind the growth is impelled by the rising count of unintended pregnancies. Subdermal contraceptive implants is an effective method to avoid unwanted pregnancies for women and couples, as it can stop pregnancies for three to five years. For instance, globally, there are more than 120 million unplanned pregnancies per year, or close to half of all pregnancies.
The rising governmental initiative to utilize contraceptive procedures are believed to fuel the market growth. For instance, the World Health Organization (WHO) is supporting nations to better their contraceptive policies and practices and also taking part in the development of new contraceptive methods.
Growth Drivers
Challenges
Additionally, implanon (etonogestrel) a contraceptive used to prevent pregnancy can cause serious eye symptoms, serious heart symptoms, and severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination. Furthermore, it should not be used at the time of pregnancy as it can lead to a certain serious pregnancy issue (ectopic pregnancy).
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~9% |
|
Base Year Market Size (2023) |
~ USD 1.06 Billion |
|
Forecast Year Market Size (2036) |
~ USD 3 Billion |
|
Regional Scope |
|
Product (Etonogestrel Implant, Levonorgestrel Implant)
The etonogestrel implant segment is estimated to hold 66% share of the global subdermal contraceptive implants market during the forecast period. Etonogestrel implant is a hormonal birth control method that comes in the form of a flexible plastic matchstick-sized rod. Additionally, the U.S. Food and Drug Administration has given the etonogestrel subdermal implant approval for contraception for up to three years as a highly effective contraceptive option for women. Moreover, the etonogestrel implant has a failure rate of less than 1%, making it more efficient than female sterilization.
Application (Hospital, Gynecology Clinics, Research Facilities, Women Healthcare Centers)
Subdermal contraceptive implants market from the hospital segment is set to garner a notable share shortly. Subdermal contraceptive implant procedure is usually performed within the hospital premises whereby the gynecologist places the implant in the non-dominant arm, typically, in the consultation room by using a local anesthetic. Besides this, sometimes there may be a need for specialized procedures, including hospital surgery if it gets difficult to remove the implant, or it cannot be found.
Type (Biodegradable, Non-Biodegradable)
Subdermal contraceptive implants market from the biodegradable segment is set to garner significant share by the year 2036. Levonorgestrel (LNG) biodegradable subcutaneous implants have emerged as the most promising long-term contraceptive methods as they release a contraceptive steroid for a predetermined amount of time before dissolving. Besides this, a subdermal biodegradable contraceptive implant is used to provide secure and reliable contraception, as it is a low-cost, biodegradable implant system in the form of a subdermal pellet, is extremely adaptable, and does not need to be surgically removed.
Our in-depth analysis of the global subdermal contraceptive implants market includes the following segments:
|
Product |
|
|
Application |
|
|
Type |
|
North American Market Forecast
Subdermal contraceptive implants market in North America is predicted to account for the largest share of 55% by 2036 impelled by the availability of contraceptive implants. Nexplanon which resembles a matchstick in size and is a tiny, thin rod is the implant that is offered in the US. Besides this, Canada has now authorized the use of Nexplanon to give patients in the country an essential and long-overdue expansion of their options for contraception. For instance, Women in the US had access to over 50% of the contraceptive products available globally, as compared to approximately 34% for Canadian women.
APAC Market Statistics
The APAC subdermal contraceptive implants market is estimated to be the second largest, during the forecast timeframe led by rising government’s initiatives to improve access to contraceptive methods. The Indian government has made important strides towards enhancing sexual and reproductive health at the national, local, and rural levels by launching various initiatives such as Mission Parivar Vikas, which will greatly expand access to family planning and contraceptives. For instance, lately, India's adoption of the Sustainable Development Goals (SDG) indicator over 3 intends to ensure that everyone has access to sexual and reproductive health care services by 2030 by meeting three-fourths of family planning needs with contemporary contraceptive methods.
Author Credits: Radhika Gupta, Shivam Bhutani
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?